FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2755004621> ?p ?o ?g. }

• W2755004621 endingPage "617" @default.
• W2755004621 startingPage "611" @default.
• W2755004621 abstract "Recent evidence has raised concerns regarding the safety of the everolimus-eluting bioresorbable vascular scaffold (E-BVS) (Absorb, Abbott Vascular, Santa Clara, CA, USA). Following these data, the use of this device has diminished in the Netherlands; however, daily practice data are limited. Therefore we studied the incidence of safety and efficacy outcomes with this device in daily clinical practice in a single large tertiary centre in the Netherlands.All E‑BVS treated patients were included in this analysis. The primary endpoint was target lesion failure (TLF), a composite of cardiac death, target vessel non-fatal myocardial infarction (TV-MI) and clinically-driven target lesion revascularisation (TLR). The secondary endpoint was the incidence of definite scaffold thrombosis.Between October 2013 and January 2017, 105 patients were treated with 147 E‑BVS. This population contained 42 (40%) patients with diabetes mellitus and 43 (40.9%) undergoing treatment for acute coronary syndrome, and thus represents a high-risk patient cohort. Mean follow-up was 19.8 months. Intravascular imaging guidance during scaffold implantation was used in 64/105 (43.5%) patients. The primary endpoint (TLF) occurred in 3 (2.9%) patients. All-cause mortality and cardiac mortality occurred in 2 (2%) and 0 (0%) patients respectively. TV-MI occurred in 2 patients (1.9%): both were periprocedural and not related to the BVS implantation. TLR occurred in 1 patient (1.0%) during follow-up. No definite scaffold thrombosis occurred during follow-up.This single-centre study examining the real-world experience of E‑BVS implantation in a high-risk population shows excellent procedural safety and long-term clinical outcomes." @default.
• W2755004621 created "2017-09-25" @default.
• W2755004621 creator A5002885109 @default.
• W2755004621 creator A5005914128 @default.
• W2755004621 creator A5039762243 @default.
• W2755004621 creator A5046384460 @default.
• W2755004621 creator A5047221417 @default.
• W2755004621 creator A5074313674 @default.
• W2755004621 creator A5077305881 @default.
• W2755004621 creator A5089329493 @default.
• W2755004621 date "2017-09-14" @default.
• W2755004621 modified "2023-10-17" @default.
• W2755004621 title "Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience" @default.
• W2755004621 cites W1489581089 @default.
• W2755004621 cites W154424083 @default.
• W2755004621 cites W1828052992 @default.
• W2755004621 cites W1918239401 @default.
• W2755004621 cites W1959089639 @default.
• W2755004621 cites W2016130878 @default.
• W2755004621 cites W2038037688 @default.
• W2755004621 cites W2042531431 @default.
• W2755004621 cites W2084425144 @default.
• W2755004621 cites W2087150869 @default.
• W2755004621 cites W2107339273 @default.
• W2755004621 cites W2125191621 @default.
• W2755004621 cites W2129036700 @default.
• W2755004621 cites W2136612769 @default.
• W2755004621 cites W2167656515 @default.
• W2755004621 cites W2192900388 @default.
• W2755004621 cites W2198697034 @default.
• W2755004621 cites W2252647110 @default.
• W2755004621 cites W2279719203 @default.
• W2755004621 cites W2529490941 @default.
• W2755004621 cites W2536813574 @default.
• W2755004621 cites W2542709139 @default.
• W2755004621 cites W2543693155 @default.
• W2755004621 cites W2547338502 @default.
• W2755004621 cites W2598919558 @default.
• W2755004621 cites W4205653014 @default.
• W2755004621 cites W4211104669 @default.
• W2755004621 doi "https://doi.org/10.1007/s12471-017-1038-4" @default.
• W2755004621 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5653537" @default.
• W2755004621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28913627" @default.
• W2755004621 hasPublicationYear "2017" @default.
• W2755004621 type Work @default.
• W2755004621 sameAs 2755004621 @default.
• W2755004621 citedByCount "0" @default.
• W2755004621 crossrefType "journal-article" @default.
• W2755004621 hasAuthorship W2755004621A5002885109 @default.
• W2755004621 hasAuthorship W2755004621A5005914128 @default.
• W2755004621 hasAuthorship W2755004621A5039762243 @default.
• W2755004621 hasAuthorship W2755004621A5046384460 @default.
• W2755004621 hasAuthorship W2755004621A5047221417 @default.
• W2755004621 hasAuthorship W2755004621A5074313674 @default.
• W2755004621 hasAuthorship W2755004621A5077305881 @default.
• W2755004621 hasAuthorship W2755004621A5089329493 @default.
• W2755004621 hasBestOaLocation W27550046211 @default.
• W2755004621 hasConcept C120665830 @default.
• W2755004621 hasConcept C121332964 @default.
• W2755004621 hasConcept C126322002 @default.
• W2755004621 hasConcept C141071460 @default.
• W2755004621 hasConcept C203092338 @default.
• W2755004621 hasConcept C2779699572 @default.
• W2755004621 hasConcept C2780400711 @default.
• W2755004621 hasConcept C2780868729 @default.
• W2755004621 hasConcept C2781464078 @default.
• W2755004621 hasConcept C2908647359 @default.
• W2755004621 hasConcept C500558357 @default.
• W2755004621 hasConcept C535046627 @default.
• W2755004621 hasConcept C61511704 @default.
• W2755004621 hasConcept C71924100 @default.
• W2755004621 hasConcept C99454951 @default.
• W2755004621 hasConceptScore W2755004621C120665830 @default.
• W2755004621 hasConceptScore W2755004621C121332964 @default.
• W2755004621 hasConceptScore W2755004621C126322002 @default.
• W2755004621 hasConceptScore W2755004621C141071460 @default.
• W2755004621 hasConceptScore W2755004621C203092338 @default.
• W2755004621 hasConceptScore W2755004621C2779699572 @default.
• W2755004621 hasConceptScore W2755004621C2780400711 @default.
• W2755004621 hasConceptScore W2755004621C2780868729 @default.
• W2755004621 hasConceptScore W2755004621C2781464078 @default.
• W2755004621 hasConceptScore W2755004621C2908647359 @default.
• W2755004621 hasConceptScore W2755004621C500558357 @default.
• W2755004621 hasConceptScore W2755004621C535046627 @default.
• W2755004621 hasConceptScore W2755004621C61511704 @default.
• W2755004621 hasConceptScore W2755004621C71924100 @default.
• W2755004621 hasConceptScore W2755004621C99454951 @default.
• W2755004621 hasIssue "11" @default.
• W2755004621 hasLocation W27550046211 @default.
• W2755004621 hasLocation W27550046212 @default.
• W2755004621 hasLocation W27550046213 @default.
• W2755004621 hasLocation W27550046214 @default.
• W2755004621 hasLocation W27550046215 @default.
• W2755004621 hasLocation W27550046216 @default.
• W2755004621 hasOpenAccess W2755004621 @default.
• W2755004621 hasPrimaryLocation W27550046211 @default.
• W2755004621 hasRelatedWork W1884611235 @default.
• W2755004621 hasRelatedWork W1918239401 @default.

• next